Terms ending in 2036
Every in-force patent on 3-D Matrix, Ltd.'s record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,298,397 | Hemostatic Composition and Hemostatic Method Using Hemostatic Composition In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 12,138,291 | Hemostatic Composition and Hemostatic Method Using Hemostatic Composition In force · High confidence | 3-D Matrix, Ltd. | In force | High confidence | |
| US 10,814,038 | Combination Compositions In force · High confidence | Vicus Therapeutics, LLC | In force | High confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by 3-D Matrix, Ltd..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.